(Q46464414)

22 December 2017

title

COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population (English)

1 reference

22 December 2017

0 references

5

1 reference

22 December 2017

author name string

Pilar Armero

1

1 reference

22 December 2017

Clemente Muriel

2

1 reference

22 December 2017

Juan Santos

3

1 reference

22 December 2017

F J Sànchez-Montero

4

1 reference

22 December 2017

Rogelio González-Sarmiento

6

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

published in

European Journal of Pain

1 reference

22 December 2017

volume

9

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

229-232

1 reference

22 December 2017

Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive-compulsive disorder

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Human liver catechol-O-methyltransferase pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Significance of the catechol-O-methyltransferase gene polymorphism in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Update on the genetics of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Human catechol-O-methyltransferase down-regulation by estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

The genetic mediation of individual differences in sensitivity to pain and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Recent advances in the genetics of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Variability and validity of polymorphism association studies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Organization of Endogenous Opiate and Nonopiate Pain Control Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

Pathobiology of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2004.06.005

10.1016/J.EJPAIN.2004.06.005

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017